Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
In order to investigate the time window of acute intracerebral hemorrhage(AICH) by "Blood
Activating and Stasis Dispersing" therapy and to verify traditional methods if it would
influence or enlarge the brain hematoma, test is made by random double-blind controlled.
Patients are classified to （0-6h）and (6-72h) teams. Herbs is separated too. The period of the
therapy lasts two weeks, and the follow up should last three months. The main indexes are
mortality rate, disability rate and the brain hematoma situation. The review is made by the
reference to (NIHSS),(GCS) and so on. So, the window time is determined through this test.
Phase:
Phase 4
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine